Earningsreport

Q4/2024 12/31/2024 EPS -0.330 ZacksConsensus -0.340 ActVsEst 0.010 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors